Wide variation in the cost of common diagnostic tests significantly contributes to healthcare cost inflation and standardizing prices could save billions annually, according to a recent UnitedHealth report.
This week’s Medicare updates include a final rule on Medicare Advantage drug pricing, the quarterly update for HCPCS drug/biological codes, an update to claim status and claim status category codes, and more!
The National Association of Healthcare Revenue Integrity (NAHRI) is pleased to announce Revenue Integrity Week, a national week of recognition for revenue integrity professionals, to be held June 3–7. This year’s theme is Scale New Heights: Elevate Your Profession and Career.
CMS modified its proposal to expand prior authorization and step therapy to protected classes of drugs for Part D and Medicare Advantage beneficiaries, according to a final rule released May 16.
This week’s Medicare updates include a new Home Health Change of Care Notice, a final rule regarding drug pricing transparency, new information on patient relationship categories and codes, and more!
